EDINBURGH PHARMACEUTICAL PROCESSES LIMITED Financials
- Company number
- SC139471Copy
Copy - Industry
- Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)
- Registered office
- Epp Environmental Centre (40) Bush Estate, Bush Loan, Penicuik, Midlothian EH26 0PH
- Incorporated
- 27/07/1992
Company snapshot
- Status
- Active
- Employees
- 0 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
3.29%vs 20242024: £1.37M
Total Assets
-0.47%vs 20242024: £2.11M
Cash in Bank
-37.93%vs 20242024: £53.19K
Total Liabilities
-7.41%vs 20242024: £741.42K
Employees
0vs 20242024: 0
In 2025, EDINBURGH PHARMACEUTICAL PROCESSES LIMITED reported net assets of £1.42M. The same filing shows total assets of £2.10M, cash in bank of £33.02K and total liabilities of £686.45K. Reported headcount was 0 in 2025. Total Liabilities fell from £741.42K in 2024 to £686.45K in 2025 (-7.41%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
3.29%from £1.37M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures EDINBURGH PHARMACEUTICAL PROCESSES LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+4.3%vs 2023+2.1% a year compound (CAGR)
Cash in Bank
+13%vs 2023+6.3% a year compound (CAGR)
Total Assets
+1%vs 2023+0.5% a year compound (CAGR)
Total Liabilities
-5.3%vs 2023-2.7% a year compound (CAGR)
Employees
-100%vs 2023-20Biggest increase
Cash in Bank+13%
£29.22K in 2023 to £33.02K in 2025
Biggest decrease
Employees-100%
20 in 2023 to 0 in 2025
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from EDINBURGH PHARMACEUTICAL PROCESSES LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 67.35%2025
- Liabilities to total assets
- 32.65%2025
- Cash to liabilities
- 4.81%2025
- Cash to total assets
- 1.57%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for EDINBURGH PHARMACEUTICAL PROCESSES LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 1.44M | 1.44M | 1.36M | 1.37M | 1.42M |
| Total Assets£ | 2.03M | 2.02M | 2.08M | 2.11M | 2.10M |
| Cash in Bank£ | 149.31K | 51.72K | 29.22K | 53.19K | 33.02K |
| Total Liabilities£ | 589.81K | 579.63K | 724.82K | 741.42K | 686.45K |
| Employees | 22 | 21 | 20 | 0 | 0 |
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has EDINBURGH PHARMACEUTICAL PROCESSES LIMITED filed financial statements?
Yes. Okredo holds filed figures for EDINBURGH PHARMACEUTICAL PROCESSES LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did EDINBURGH PHARMACEUTICAL PROCESSES LIMITED report in 2025?
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED reported net assets of £1.42M for 2025. That compares with £1.37M in 2024, a change of 3.29%.
What total assets did EDINBURGH PHARMACEUTICAL PROCESSES LIMITED report in 2025?
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED reported total assets of £2.10M for 2025. That compares with £2.11M in 2024, a change of -0.47%.
What cash in bank did EDINBURGH PHARMACEUTICAL PROCESSES LIMITED report in 2025?
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED reported cash in bank of £33.02K for 2025. That compares with £53.19K in 2024, a change of -37.93%.
How many people does EDINBURGH PHARMACEUTICAL PROCESSES LIMITED employ?
EDINBURGH PHARMACEUTICAL PROCESSES LIMITED reported 0 employees in 2025, compared with 0 in 2024.
How have EDINBURGH PHARMACEUTICAL PROCESSES LIMITED financials changed over the last 3 years?
Between 2023 and 2025, EDINBURGH PHARMACEUTICAL PROCESSES LIMITED's net assets rose by 4.3%, cash in bank rose by 13%, total assets rose by 1% and total liabilities fell by 5.3%. Net assets compounded at 2.1% a year across the two years to 2025, from £1.36M to £1.42M. Reported headcount went from 20 in 2023 to 0 in 2025 (-20).
Which years of EDINBURGH PHARMACEUTICAL PROCESSES LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.